You are here

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

Last updated on February 18, 2019

FOR MORE INFORMATION
Study Location
University of Arizona Cancer Center - North Campus
Tucson, Arizona, 85719 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Non-small Cell Lung Cancer, Urothelial Cancer
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

• Eligible tumor type diagnosis

– Non-squamous NSCLC

– Cisplatin-eligible UC

• No prior systemic treatment for unresectable locally advanced or metastatic disease for given tumor type. If prior therapy in adjuvant or neoadjuvant setting, disease free interval must be > 6 months for NSCLC and > 12 months for UC.

• Measurable disease by RECIST v1.1 with ≥ 1 measurable lesion

• Available tumor specimen at baseline (archived ≤12 months or de novo biopsy)

• Age ≥ 18 years

• ECOG 0 or 1

• Adequate hepatic, renal, and bone marrow function per protocol.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details
Trial Details
Administration
The form in which the study drug will be delivered to the patient's body.
Intravenous injections
Placebo
A placebo often looks like the investigational medication, but it has no active ingredient in it.
A placebo is not used in this trial
Prior Approval
The study drug has not been approved yet.
Post-Trial Access to Study Drug
Possible
NCT03317496
Pfizer
Recruiting
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Non-small Cell Lung Cancer
NCT00113516
All Genders
18+
Years
Multiple Sites
Non-Small Cell Lung Cancer
NCT00965731
All Genders
18+
Years
Multiple Sites
Non-Small Cell Lung Cancer, Urothelial Cancer
NCT03472560
All Genders
18+
Years
Multiple Sites
Pancreatic Cancer, Non-Small Cell Lung Cancer, Cancer
NCT03637491
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now